Women with lower socioeconomic status are among those at a higher risk for developing postpartum depression—and the new treatment is estimated to cost $34,000 per patient.
Scientists have studied the potential for ketamine to treat severe depression for years, but this is the first time the FDA has indicated its use as an antidepressant.
The Supreme Court denied Domineque Ray's request to have his Muslim imam in the room during his lethal injection, raising questions of religious discrimination. But his trial and death sentence were an uphill battle from the start.